Publications by authors named "Elda Tagliabue"

100Publications

Inhibition of the Wnt Signalling Pathway: An Avenue to Control Breast Cancer Aggressiveness.

Int J Mol Sci 2020 Nov 28;21(23). Epub 2020 Nov 28.

Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Via Amadeo 42, 20133 Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms21239069DOI Listing
November 2020

Mechanisms of hyperprogressive disease after immune checkpoint inhibitor therapy: what we (don't) know.

J Exp Clin Cancer Res 2020 Nov 9;39(1):236. Epub 2020 Nov 9.

Dipartimento di Scienze Biomediche per la Salute, Università degli Studi di Milano, via Mangiagalli 31, 20133, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13046-020-01721-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7650183PMC
November 2020

Infrared Spectroscopic Imaging Visualizes a Prognostic Extracellular Matrix-Related Signature in Breast Cancer.

Sci Rep 2020 03 25;10(1):5442. Epub 2020 Mar 25.

Departments of Bioengineering, Electrical and Computer Engineering, Mechanical Science and Engineering, Chemical and Biomolecular Engineering and Chemistry, University of Illinois at Urbana-Champaign, Urbana, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-020-62403-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096505PMC
March 2020

Adipocytes in Breast Cancer, the Thick and the Thin.

Cells 2020 02 27;9(3). Epub 2020 Feb 27.

Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cells9030560DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140407PMC
February 2020

Cancer Stem Cells: Devil or Savior-Looking behind the Scenes of Immunotherapy Failure.

Cells 2020 02 27;9(3). Epub 2020 Feb 27.

Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Via Amadeo 42, 20133 Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cells9030555DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140486PMC
February 2020

TLR3 Expression Induces Apoptosis in Human Non-Small-Cell Lung Cancer.

Int J Mol Sci 2020 Feb 20;21(4). Epub 2020 Feb 20.

Dipartimento di Scienze Biomediche per la Salute, Università degli Studi di Milano, 20133 Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms21041440DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073031PMC
February 2020

Combined targeting of EGFR and HER2 against prostate cancer stem cells.

Cancer Biol Ther 2020 05 23;21(5):463-475. Epub 2020 Feb 23.

Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/15384047.2020.1727702DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7515488PMC
May 2020

ELISA assay employing epitope-specific monoclonal antibodies to quantify circulating HER2 with potential application in monitoring cancer patients undergoing therapy with trastuzumab.

Sci Rep 2020 02 20;10(1):3016. Epub 2020 Feb 20.

Regional Center for Biomarkers, Department of Clinical Pathology and Transfusion Medicine, Azienda ULSS 3 Serenissima, Regional Hospital, Campo SS Giovanni e Paolo 6777, 30122, Venice (VE), Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-020-59630-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7033231PMC
February 2020

The lung microbiota: role in maintaining pulmonary immune homeostasis and its implications in cancer development and therapy.

Cell Mol Life Sci 2020 Jul 23;77(14):2739-2749. Epub 2020 Jan 23.

Dipartimento Di Scienze Biomediche Per La Salute, Università Degli Studi Di Milano, via Mangiagalli 31, 20133, Milano, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00018-020-03452-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326824PMC
July 2020

Non-Human Determinants of Lung Cancer Outcome: A Target for Inhibition of Pro-Metastatic Effect of Surgery, Triggered by Postoperative Bacterial Pneumonia.

J Thorac Oncol 2019 12;14(12):2039-2041

Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2019.09.084DOI Listing
December 2019

Local Administration of Caloric Restriction Mimetics to Promote the Immune Control of Lung Metastases.

J Immunol Res 2019 20;2019:2015892. Epub 2019 Jun 20.

Dipartimento di Scienze Biomediche per la Salute, Università degli Studi di Milano, Milan 20133, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2019/2015892DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609366PMC
December 2019

Decoding Immune Heterogeneity of Triple Negative Breast Cancer and Its Association with Systemic Inflammation.

Cancers (Basel) 2019 Jun 28;11(7). Epub 2019 Jun 28.

Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers11070911DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678607PMC
June 2019

The d16HER2 Splice Variant: A Friend or Foe of HER2-Positive Cancers?

Cancers (Basel) 2019 Jun 28;11(7). Epub 2019 Jun 28.

Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers11070902DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678616PMC
June 2019

Tumor Extracellular Matrix Remodeling: New Perspectives as a Circulating Tool in the Diagnosis and Prognosis of Solid Tumors.

Cells 2019 01 23;8(2). Epub 2019 Jan 23.

Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori di, 20133 Milano, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cells8020081DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406979PMC
January 2019

HER2 signaling regulates the tumor immune microenvironment and trastuzumab efficacy.

Oncoimmunology 2019 21;8(1):e1512942. Epub 2018 Sep 21.

Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori of Milan, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2018.1512942DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6287794PMC
September 2018

Early immune modulation by single-agent trastuzumab as a marker of trastuzumab benefit.

Br J Cancer 2018 12 27;119(12):1487-1494. Epub 2018 Nov 27.

Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milano, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41416-018-0318-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288086PMC
December 2018

Quantification of Circulating Cancer Biomarkers via Sensitive Topographic Measurements on Single Binder Nanoarrays.

ACS Omega 2017 Jun 13;2(6):2618-2629. Epub 2017 Jun 13.

NanoInnovation Lab, Elettra-Sincrotone S.C.p.A., ss 14 km 163.5 in Area Science Park, 34149 Basovizza-Trieste, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/acsomega.7b00284DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6044866PMC
June 2017

cIAP1 regulates the EGFR/Snai2 axis in triple-negative breast cancer cells.

Cell Death Differ 2018 12 19;25(12):2147-2164. Epub 2018 Apr 19.

Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Molecular Mechanisms of Cell Cycle Control Unit, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41418-018-0100-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6262016PMC
December 2018

MicroRNA co-expression patterns unravel the relevance of extra cellular matrix and immunity in breast cancer.

Breast 2018 Jun 26;39:46-52. Epub 2018 Mar 26.

Molecular Targeting Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.breast.2018.03.008DOI Listing
June 2018

Extracellular matrix proteins as diagnostic markers of breast carcinoma.

J Cell Physiol 2018 08 9;233(8):6280-6290. Epub 2018 Mar 9.

Molecular Targeting Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcp.26513DOI Listing
August 2018

Predicting the Efficacy of HER2-Targeted Therapies: A Look at the Host.

Dis Markers 2017 18;2017:7849108. Epub 2017 Dec 18.

Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2017/7849108DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5748305PMC
August 2018

Exploiting poly(I:C) to induce cancer cell apoptosis.

Cancer Biol Ther 2017 Oct 7;18(10):747-756. Epub 2017 Sep 7.

b Università degli Studi di Milano , Dipartimento di Scienze Biomediche per la Salute , via Mangiagalli 31, Milan , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/15384047.2017.1373220DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678690PMC
October 2017

Antibody-mediated blockade of JMJD6 interaction with collagen I exerts antifibrotic and antimetastatic activities.

FASEB J 2017 12 8;31(12):5356-5370. Epub 2017 Aug 8.

Molecular Immunology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori, Milan, Italy;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1096/fj.201700377RDOI Listing
December 2017

Cancer acidity: An ultimate frontier of tumor immune escape and a novel target of immunomodulation.

Semin Cancer Biol 2017 04 6;43:74-89. Epub 2017 Mar 6.

Unit of Immunotherapy of Human Tumors, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semcancer.2017.03.001DOI Listing
April 2017

Activation of NK cell cytotoxicity by aerosolized CpG-ODN/poly(I:C) against lung melanoma metastases is mediated by alveolar macrophages.

Cell Immunol 2017 03 5;313:52-58. Epub 2017 Jan 5.

Dipartimento di Scienze Biomediche per la Salute, Università degli Studi di Milano, via Magiagalli 31, 20133 Milan, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cellimm.2017.01.004DOI Listing
March 2017

Reprogramming the lung microenvironment by inhaled immunotherapy fosters immune destruction of tumor.

Oncoimmunology 2016 20;5(11):e1234571. Epub 2016 Sep 20.

Dipartimento di Scienze Biomediche per la Salute, Università degli Studi di Milano , Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2016.1234571DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5139640PMC
September 2016

Expression and prognostic significance of the autoimmune regulator gene in breast cancer cells.

Cell Cycle 2016 Dec 18;15(23):3220-3229. Epub 2016 Oct 18.

a Dipartimento di Scienze Biomediche per la Salute , Università degli Studi di Milano , Milan , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/15384101.2016.1241918DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5176139PMC
December 2016

Breast cancer-secreted miR-939 downregulates VE-cadherin and destroys the barrier function of endothelial monolayers.

Cancer Lett 2017 01 28;384:94-100. Epub 2016 Sep 28.

Molecular Targeting Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Amadeo 42, 20133 Milan, Italy.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03043835163055
Publisher Site
http://dx.doi.org/10.1016/j.canlet.2016.09.013DOI Listing
January 2017

Mesenchymal Transition of High-Grade Breast Carcinomas Depends on Extracellular Matrix Control of Myeloid Suppressor Cell Activity.

Cell Rep 2016 09;17(1):233-248

Molecular Immunology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale Tumori, 20133 Milan, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2016.08.075DOI Listing
September 2016

Association of adiposity, dysmetabolisms, and inflammation with aggressive breast cancer subtypes: a cross-sectional study.

Breast Cancer Res Treat 2016 05 27;157(1):179-89. Epub 2016 Apr 27.

Analytic Epidemiology and Health Impact Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-016-3802-3DOI Listing
May 2016

Predictive biomarkers in the treatment of HER2-positive breast cancer: an ongoing challenge.

Future Oncol 2016 Jun 23;12(11):1413-28. Epub 2016 Mar 23.

Molecular Targeting Unit, Department of Experimental Oncology & Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2015-0025DOI Listing
June 2016

CpG-oligodeoxynucleotides exert remarkable antitumor activity against diffuse malignant peritoneal mesothelioma orthotopic xenografts.

J Transl Med 2016 Jan 25;14:25. Epub 2016 Jan 25.

Molecular Pharmacology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12967-016-0781-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4727408PMC
January 2016

miR-302b enhances breast cancer cell sensitivity to cisplatin by regulating E2F1 and the cellular DNA damage response.

Oncotarget 2016 Jan;7(1):786-97

Department of Molecular Virology, Immunology and Medical Genetics, College of Medicine and Solid Tumor Biology Program, Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.6381DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4808033PMC
January 2016

Taxanes enhance trastuzumab-mediated ADCC on tumor cells through NKG2D-mediated NK cell recognition.

Oncotarget 2016 Jan;7(1):255-65

Molecular Targeting Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.6353DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4807996PMC
January 2016

Tumor-extracellular matrix interactions: Identification of tools associated with breast cancer progression.

Semin Cancer Biol 2015 Dec 28;35:3-10. Epub 2015 Sep 28.

Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Via G.A. Amadeo, 42, 20133 Milan, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semcancer.2015.09.012DOI Listing
December 2015

Aerosol Delivery in the Treatment of Lung Cancer.

Curr Cancer Drug Targets 2015 ;15(7):604-12

Dipartimento di Scienze Biomediche per la Salute, Universita degli Studi di Milano, via Mangiagalli 31 20133 Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1568009615666150602143751DOI Listing
June 2016

Fhit Nuclear Import Following EGF Stimulation Sustains Proliferation of Breast Cancer Cells.

J Cell Physiol 2015 Nov;230(11):2661-70

Molecular Targeting Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcp.24968DOI Listing
November 2015

"Omics" and Immunologic Approaches to Optimizing Cure Rates in HER2-Positive Breast Carcinomas.

Front Oncol 2014 18;4:334. Epub 2014 Nov 18.

Molecular Targeting Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori , Milan , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2014.00334DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4235291PMC
December 2014

Activated d16HER2 homodimers and SRC kinase mediate optimal efficacy for trastuzumab.

Cancer Res 2014 Nov 27;74(21):6248-59. Epub 2014 Aug 27.

Molecular Targeting Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-14-0983DOI Listing
November 2014

Stromal responses among carcinomas--letter.

Clin Cancer Res 2014 Mar;20(5):1396

Authors' Affiliation: Molecular Targeting Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-3005DOI Listing
March 2014

Maspin influences response to doxorubicin by changing the tumor microenvironment organization.

Int J Cancer 2014 Jun 30;134(12):2789-97. Epub 2013 Nov 30.

Molecular Targeting Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.28608DOI Listing
June 2014

Increased sensitivity to chemotherapy induced by CpG-ODN treatment is mediated by microRNA modulation.

PLoS One 2013 6;8(3):e58849. Epub 2013 Mar 6.

Functional Genomics Core Facility, Fondazione Istituto Di Ricovero e Cura a Carattere Scientifico Istituto Nazionale dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0058849PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590172PMC
September 2013

High efficacy of CpG-ODN, cetuximab and cisplatin combination for very advanced ovarian xenograft tumors.

J Transl Med 2013 Jan 29;11:25. Epub 2013 Jan 29.

Dipartimento di Scienze Biomediche per la Salute, Università degli Studi di Milano, via Mangiagalli 31, 20133, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1479-5876-11-25DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571944PMC
January 2013

Anti-tumor activity of CpG-ODN aerosol in mouse lung metastases.

Int J Cancer 2013 Jul 12;133(2):383-93. Epub 2013 Feb 12.

Dipartimento di Scienze Biomediche per Salute, Università degli Studi di Milano, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.28028DOI Listing
July 2013

Surveillance of spontaneous breast cancer metastasis by TRAIL-expressing CD34⁺ cells in a xenograft model.

Breast Cancer Res Treat 2012 Nov 11;136(2):457-67. Epub 2012 Oct 11.

Dipartimento di Scienze biomediche per la salute, Università di Milano, Via Mangiagalli 31, 20133 Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-012-2281-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3483102PMC
November 2012

EGFR through STAT3 modulates ΔN63α expression to sustain tumor-initiating cell proliferation in squamous cell carcinomas.

J Cell Physiol 2013 Apr;228(4):871-8

Molecular Targeting Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcp.24238DOI Listing
April 2013

PET prediction of response to trastuzumab in ErbB2-positive human xenograft model.

J Nucl Med 2012 Oct 23;53(10):1654-5; author reply 1655-6. Epub 2012 Aug 23.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.112.108068DOI Listing
October 2012

Modulation of DNA repair genes induced by TLR9 agonists: A strategy to eliminate "altered" cells?

Oncoimmunology 2012 Mar;1(2):258-259

Department of Human Morphology and Biomedical Sciences "Città Studi"; Università degli Studi di Milano; Milan, Italy ; Molecular Targeting Unit Fondazione IRCCS; Istituto Nazionale Tumori; Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/onci.1.2.18343DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3377000PMC
March 2012

FOXP3 expression in tumor cells and implications for cancer progression.

J Cell Physiol 2013 Jan;228(1):30-5

Molecular Targeting Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS-Istituto Nazionale dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcp.24125DOI Listing
January 2013

Oncosuppressive role of p53-induced miR-205 in triple negative breast cancer.

Mol Oncol 2012 Aug 19;6(4):458-72. Epub 2012 Apr 19.

Departments of Molecular Virology, Immunology and Human Genetics, Comprehensive Cancer Center, Ohio State University, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molonc.2012.03.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3679926PMC
August 2012

Promise and failure of targeted therapy in breast cancer.

Front Biosci (Schol Ed) 2012 Jan 1;4:356-74. Epub 2012 Jan 1.

Sbarro Institute for Cancer Research and Molecular Medicine, College of Science and Technology, Temple University BioLife Science, Philadelphia, PA 19122, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2741/273DOI Listing
January 2012

The HER2 World: Better Treatment Selection for Better Outcome.

J Natl Cancer Inst Monogr 2011 ;2011(43):82-5

Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jncimonographs/lgr041DOI Listing
March 2012

Breast cancer and microRNAs: therapeutic impact.

Breast 2011 Oct;20 Suppl 3:S63-70

Molecular Targeting Unit, Department of Experimental Oncology, Fondazione IRCCS, Istituto Nazionale Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0960-9776(11)70297-1DOI Listing
October 2011

Activity and resistance of trastuzumab according to different clinical settings.

Cancer Treat Rev 2012 May 2;38(3):212-7. Epub 2011 Jul 2.

Molecular Targeting Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2011.06.002DOI Listing
May 2012

Do pre-diagnostic drinking habits influence breast cancer survival?

Tumori 2011 Mar-Apr;97(2):142-8

Department of Preventive and Predictive Medicine, Analytical Epidemiology Unit, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1700/667.7774DOI Listing
July 2011

Induction of Paneth cell degranulation by orally administered Toll-like receptor ligands.

J Cell Physiol 2012 Mar;227(3):1107-13

Department of Human Morphology and Biomedical Sciences Città Studi University of Milan, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcp.22830DOI Listing
March 2012

Potential role of HER2-overexpressing exosomes in countering trastuzumab-based therapy.

J Cell Physiol 2012 Feb;227(2):658-67

Molecular Targeting Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS, Istituto Nazionale Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcp.22773DOI Listing
February 2012

HER2 as a target for breast cancer therapy.

Expert Opin Biol Ther 2010 May;10(5):711-24

Molecular Targeting Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS, Istituto Nazionale dei Tumori, via G Venezian 1, 20133 Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14712591003689972DOI Listing
May 2010

Influence of lignans depletion on murine mammary gland morphology.

Nutr Cancer 2010 ;62(2):237-42

Universita degli Studi di Milano, 20133 Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/01635580903305284DOI Listing
March 2010